salicylic acid 20 MG/ML Topical Solution [Clenziderm]

RxCUI: 1235208
RxNorm name: salicylic acid 20 MG/ML Topical Solution [Clenziderm]
Term type: SBD
Status: Active
Updated: 2026-07-19 06:51:57

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 012012
Active start: 012012
Multiple ingredient: NO
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
salicylic acid	20 MG / 1 ML	salicylic acid	salicylic acid

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Topical Solution	316986

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
salicylic acid	9525

Source Vocabulary Codes#

Code type, Value, Category table
Code type	Value	Category
RXNAV_STR	Clenziderm M.D. 2 % Pore Therapy	NAMES
RxNorm Name	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	NAMES
RxNorm Synonym	Clenziderm 20 MG/ML Topical Solution	NAMES
RxNorm Synonym	Clenziderm M.D. 2 % Pore Therapy	NAMES
TTY	SBD	ATTRIBUTES
SPL_SET_ID	08ba9ea8-73fd-472b-9cc4-67df167352ec	CODES
SPL_SET_ID	08c1a55e-a376-4cd6-896f-0ad2068a1fc0	CODES
SPL_SET_ID	7710e51a-dd3a-4f44-8c97-c089c6817cb0	CODES
RxCUI	1235208	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
62032-612-04	62032-612	CLENZIDERM PORE THERAPY SALICYLIC ACID	Obagi Cosmeceuticals LLC	M006

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
M006	62032-612	CLENZIDERM PORE THERAPY SALICYLIC ACID	OTC MONOGRAPH DRUG	Obagi Cosmeceuticals LLC

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11	Source	Active
62032061204	rxnav_ndcs	yes
00187610204	rxnav_historical
62032011060	rxnav_historical
69269011060	rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
08ba9ea8-73fd-472b-9cc4-67df167352ec	Clenziderm 20 MG/ML Topical Solution	SY	3	Obagi ® Skintrinsiq™ Clarifiying Protocol Kit	20250321
08ba9ea8-73fd-472b-9cc4-67df167352ec	CLENZIderm M.D. 2 % Pore Therapy Topical Solution	PSN	3	Obagi ® Skintrinsiq™ Clarifiying Protocol Kit	20250321
08ba9ea8-73fd-472b-9cc4-67df167352ec	Clenziderm M.D. 2 % Pore Therapy	SY	3	Obagi ® Skintrinsiq™ Clarifiying Protocol Kit	20250321
08ba9ea8-73fd-472b-9cc4-67df167352ec	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	SBD	3	Obagi ® Skintrinsiq™ Clarifiying Protocol Kit	20250321
7710e51a-dd3a-4f44-8c97-c089c6817cb0	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	SBD	3	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	20250319
7710e51a-dd3a-4f44-8c97-c089c6817cb0	Clenziderm 20 MG/ML Topical Solution	SY	3	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	20250319
7710e51a-dd3a-4f44-8c97-c089c6817cb0	Clenziderm M.D. 2 % Pore Therapy	SY	3	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	20250319
7710e51a-dd3a-4f44-8c97-c089c6817cb0	CLENZIderm M.D. 2 % Pore Therapy Topical Solution	PSN	3	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	20250319
08c1a55e-a376-4cd6-896f-0ad2068a1fc0	CLENZIderm M.D. 2 % Pore Therapy Topical Solution	PSN	3	CLENZIDERM PORE THERAPY ACNE TREATMENT	20250101
08c1a55e-a376-4cd6-896f-0ad2068a1fc0	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	SBD	3	CLENZIDERM PORE THERAPY ACNE TREATMENT	20250101
08c1a55e-a376-4cd6-896f-0ad2068a1fc0	Clenziderm M.D. 2 % Pore Therapy	SY	3	CLENZIDERM PORE THERAPY ACNE TREATMENT	20250101
08c1a55e-a376-4cd6-896f-0ad2068a1fc0	Clenziderm 20 MG/ML Topical Solution	SY	3	CLENZIDERM PORE THERAPY ACNE TREATMENT	20250101
934ec314-1ab7-45ee-a2fe-8bff3ff981b6	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	SBD	1	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	20120510
934ec314-1ab7-45ee-a2fe-8bff3ff981b6	Clenziderm M.D. 2 % Pore Therapy	SY	1	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	20120510
934ec314-1ab7-45ee-a2fe-8bff3ff981b6	CLENZIderm M.D. 2 % Pore Therapy Topical Solution	PSN	1	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	20120510
934ec314-1ab7-45ee-a2fe-8bff3ff981b6	Clenziderm 20 MG/ML Topical Solution	SY	1	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	20120510
852f01d0-5859-4482-a1fa-91827c964001	CLENZIderm M.D. 2 % Pore Therapy Topical Solution	PSN	1	OBAGI ® CLENZIderm M.D.™ Pore Therapy	20111215
852f01d0-5859-4482-a1fa-91827c964001	Clenziderm M.D. 2 % Pore Therapy	SY	1	OBAGI ® CLENZIderm M.D.™ Pore Therapy	20111215
852f01d0-5859-4482-a1fa-91827c964001	Clenziderm 20 MG/ML Topical Solution	SY	1	OBAGI ® CLENZIderm M.D.™ Pore Therapy	20111215
852f01d0-5859-4482-a1fa-91827c964001	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	SBD	1	OBAGI ® CLENZIderm M.D.™ Pore Therapy	20111215

DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
08ba9ea8-73fd-472b-9cc4-67df167352ec	Obagi ® Skintrinsiq™ Clarifiying Protocol Kit	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| Denison Pharmaceuticals, LLC \| Swiss-American CDMO, LLC \| TENCO ASSEMBLIES, INC	20250321
7710e51a-dd3a-4f44-8c97-c089c6817cb0	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| Denison Pharmaceuticals, LLC	20250319
08c1a55e-a376-4cd6-896f-0ad2068a1fc0	CLENZIDERM PORE THERAPY ACNE TREATMENT	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| Denison Pharmaceuticals, LLC	20250101
934ec314-1ab7-45ee-a2fe-8bff3ff981b6	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	OMP, INC. \| PURETEK CORPORATION \| Ei INC.	20120510
852f01d0-5859-4482-a1fa-91827c964001	OBAGI ® CLENZIderm M.D.™ Pore Therapy	OMP, INC. \| PURETEK CORPORATION \| Ei INC.	20111215

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	S01BC	Antiinflammatory agents, non-steroids	ATC1-4		salicylic acid
ATC	D01AE	Other antifungals for topical use	ATC1-4		salicylic acid
MEDRT	D020156	Salicylic Acid	CHEM	has_ingredient	salicylic acid
MEDRT	D000152	Acne Vulgaris	DISEASE	may_treat	salicylic acid
MEDRT	D012628	Dermatitis, Seborrheic	DISEASE	may_treat	salicylic acid
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	salicylic acid
MEDRT	D017492	Keratosis, Seborrheic	DISEASE	may_treat	salicylic acid
MEDRT	D011565	Psoriasis	DISEASE	may_treat	salicylic acid
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	salicylic acid
MEDRT	D014860	Warts	DISEASE	may_treat	salicylic acid
MEDRT	N0000009915	Unknown Cellular or Molecular Interaction	MOA	has_moa	salicylic acid
MEDRT	N0000009974	Increased Skin Keratinization	PE	has_pe	salicylic acid

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Clenziderm	rxnav_allrelated
DF	DF	Topical Solution	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
GPCK	GPCK	{1 (240 ML) (benzoyl peroxide 25 MG/ML Medicated Liquid Soap) / 1 (120 ML) (salicylic acid 20 MG/ML Topical Solution) / 1 (60 ML) (sulfur 50 MG/ML Topical Solution) } Pack	rxnav_allrelated
GPCK	GPCK	{1 (28000 MG) (benzoyl peroxide 0.05 MG/MG Topical Gel) / 1 (127000 MG) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (147 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack	rxnav_allrelated
GPCK	GPCK	{1 (3000 MG) (benzoyl peroxide 0.05 MG/MG Topical Gel) / 1 (28000 MG) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (26 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack	rxnav_allrelated
GPCK	GPCK	{1 (47 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (148 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack	rxnav_allrelated
IN	IN	salicylic acid	rxnav_allrelated
SBD	SBD	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	rxnav_allrelated
SBDC	SBDC	salicylic acid 20 MG/ML [Clenziderm]	rxnav_allrelated
SBDF	SBDF	salicylic acid Topical Solution [Clenziderm]	rxnav_allrelated
SBDG	SBDG	Clenziderm Topical Product	rxnav_allrelated
SCD	SCD	salicylic acid 20 MG/ML Topical Solution	rxnav_allrelated
SCDC	SCDC	salicylic acid 20 MG/ML	rxnav_allrelated
SCDF	SCDF	salicylic acid Topical Solution	rxnav_allrelated
SCDG	SCDG	salicylic acid Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	ACTIVATED	04/01/2025
ATTRIBUTES	AVAILABLE_STRENGTH	20 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	TTY	SBD
CODES	RxCUI	1235208
CODES	SPL_SET_ID	08ba9ea8-73fd-472b-9cc4-67df167352ec
CODES	SPL_SET_ID	08c1a55e-a376-4cd6-896f-0ad2068a1fc0
CODES	SPL_SET_ID	7710e51a-dd3a-4f44-8c97-c089c6817cb0
NAMES	Prescribable Synonym	CLENZIderm M.D. 2 % Pore Therapy Topical Solution
NAMES	RXNAV_STR	Clenziderm M.D. 2 % Pore Therapy
NAMES	RxNorm Name	salicylic acid 20 MG/ML Topical Solution [Clenziderm]
NAMES	RxNorm Synonym	Clenziderm 20 MG/ML Topical Solution
NAMES	RxNorm Synonym	Clenziderm M.D. 2 % Pore Therapy
SOURCES	Source	Metathesaurus FDA Structured Product Labels

salicylic acid 20 MG/ML Topical Solution [Clenziderm]

RxNorm Status History#

Ingredients And Strength#

Dose Form Concepts#

Derived Ingredient Concepts#

Source Vocabulary Codes#

FDA NDC Products And Packages#

Drugs@FDA Applications#

RxNav Current And Historical NDCs#

DailyMed RxNorm Mappings#

DailyMed Labels#

Drug Classes#

Related Concepts#

Properties#